← Back to all signals
RESEARCH PAPER ANALYSIS

Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI - a prospective multinational study.

AI interpretation is pending for this paper.

Open original publication →
PMID40982141
JournalActa neurochirurgica
Publication Date2025-09-22
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Postoperative speech impairment (POSI) and cranial nerve deficits (CND) are common complications of pediatric posterior fossa (PF) tumor surgery. Intraoperative MRI (ioMRI) has proven a useful tool in achieving gross total resection. The risk of POSI and CND with ioMRI remains unclear, making it the primary scope of this study. Additionally, we assessed whether POSI was associated with CND. METHODS: We prospectively included pediatric patients undergoing PF tumor surgery in 36 centers across 15 European countries. Neurological status and speech were assessed preoperatively and 1-4 weeks postoperatively. Surgical details, including tumor location and use of ioMRI, were recorded within 72 h of surgery. Postoperative CND were categorized as 0, 1, 2, or ≥ 3 nerves affected; POSI as habitual, reduced speech, or mutism. Proportional odds models estimated odds ratios (OR) for 1) POSI with stepwise adjustment for tumor location and age, and 2) CND with adjustment for preoperative CND and tumor location. Subgroup analyses assessed systematic differences, missing data, center-level effects, and histology adjustment. RESULTS: Of 790 primary PF tumor surgeries, 141 (18%) involved ioMRI. POSI occurred in 183/790 (23%) and postoperative CND in 213/790 (27%). POSI-risk with ioMRI showed non-significant unadjusted OR (95% CI) 0.83 (0.53;1.30); adjusted OR 0.76 (0.43;1.35). Fewer CNDs were observed with ioMRI (unadjusted OR 0.63 (0.40;1.00), adjusted OR 0.58 (0.33;0.94), p = 0.03). POSI-risk was associated with more CNDs (adjusted OR for 1 CND: 2.06 (1.15;3.68); 2 CND: 2.13 (1.02;4.42); ≥ 3 CND: 4.15 (1.98;8.70), p < 0.05). CONCLUSIONS: ioMRI was not associated with increased risk of postoperative complications in this multicenter cohort. The reduction in CND among ioMRI cases may reflect derived effects on surgical decision-making, expertise, case-load and case-mix. Results should be interpreted with caution due to limited intraoperative data. The association between POSI-risk and cumulative CND may indicate extensive brainstem involvement. Our findings highlight the need to further explore how ioMRI-guided strategies affect functional outcomes in pediatric PF tumour surgery. CLINICAL TRIALS ID: NCT02300766 (October 2014).

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Pediatric Acute Leukemias: Epidemiological, Clinical Features, and Diagnostic Contribution of Flow Cytometry in a Resource-Limited Setting. Cureus 61.5 2 Patient Care of Pregnant Women With Chronic Myeloid Leukemia in a Resource Limited Setting-Case Reports From Ghana. Case reports in hematology 63.8 3 Porto-sinusoidal vascular disorder and sinusoidal obstructive syndrome in patients treated with thiopurines: a systematic review. Annals of hepatology 75.1 4 Palbociclib in combination with dexamethasone, bortezomib, and doxorubicin for pediatric relapsed acute lymphoblastic leukemia. Blood neoplasia 49.12 5 Plasma Cell Gingivitis With Cheilitis in an Adolescent: A Case Report. Cureus 51.1 6 Efgartigimod as a salvage therapy for anti-NMDAR encephalitis patients after first-line treatment failure: a case series. Frontiers in neurology 65.18 7 Successful treatment of refractory classic juvenile pityriasis rubra pilaris with adalimumab in a 4-year-old girl: a case report. Frontiers in immunology 67.0 8 Clinical spectrum and survival outcomes of malignancies in pediatric patients with inborn errors of immunity. Frontiers in immunology 65.82 9 Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report. Frontiers in medicine 63.86 10 HPV52 predominates in cervical infections and precancerous lesions in Chongqing, China: a 6-year study linking genotypes to vaginal microecology. Frontiers in public health 61.9 11 Report from the National Pediatric Cancer Foundation - infantile glioma and other non-embryonal central nervous system tumors: evolving molecular advances and current treatment landscape. Frontiers in oncology 68.34 12 Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives. Frontiers in immunology 87.5 13 The real-world practice of fertility preservation for patients with epithelial ovarian cancer in Asian regions. Journal of gynecologic oncology 67.2 14 Multiple congenital dermal sinus tracts: a case-based review involving a unique triple-tract configuration that challenges current embryological concepts. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 49.9 15 Natural products mediate ferroptosis and immune microenvironment-linked sensitization in osteosarcoma: from chemotherapy resistance to combined therapeutic transformation. Molecular diversity 71.38 16 Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation. Acta neuropathologica communications 66.6 17 Pediatrics supratentorial intraventricular atypical teratoid/rhabdoid tumors: a case report and a systematic review of the literature. European journal of pediatrics 77.1 18 Cranial pathologies in Noonan syndrome: clinical implications for pre-growth hormone neuroimaging. European journal of pediatrics 61.4 19 Narciclasine reduces proliferation and migration of neuroblastoma cells and decreases FAK/PI3K pathway activation. Medical oncology (Northwood, London, England) 43.0 20 Balancing safe resection and spinal stability in osteoblastoma and osteoid osteoma: a retrospective study. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 67.4 21 Scaling up symptom screening for routine use in pediatric oncology: provincial implementation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 61.6 22 Extent of resection and craniopharyngioma recurrence: a volumetric analysis. Journal of neuro-oncology 66.1 23 Fertility in breast cancer survivorship: a scoping review. Journal of cancer survivorship : research and practice 81.0 24 Clinical practice guideline for psoriasis management in Latin America. Anais brasileiros de dermatologia 76.5 25 Constrained Choices and Meaning-Making: A Qualitative Study of Caregivers of Children With Hematologic Malignancies. Psycho-oncology 59.6 26 Timely Surgical Approaches for Pediatric Epilepsy Resistant to Medication. Journal of surgery and research 64.0 27 The Journey with paediatric cancer: reflections on its impact on patients and their families. The Pan African medical journal 56.0 28 Pars plana vitrectomy in uveitis of diverse etiologies: indications and surgical outcomes. BMC ophthalmology 63.5 29 Persistent Oropharyngeal Hemangioma Causing Progressive Upper Airway Compromise: Diagnostic and Therapeutic Challenges. Cureus 61.64 30 Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO open 71.84 31 Life Saving Hepatic Resections in Ruptured Pediatric Hepatoblastoma - a Report of 3 Cases. Indian journal of surgical oncology 63.6 32 Development and Internal Validation of the SPR-HCC Score System: A Prognostic Tool for Survival Prediction in Hepatocellular Carcinoma in a Resource-Limited Setting. Asian Pacific journal of cancer prevention : APJCP 72.02
PATIENT-FRIENDLY SUMMARY

Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI - a prospective multinational study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic